{"id":50469,"date":"2026-06-03T18:26:09","date_gmt":"2026-06-03T12:56:09","guid":{"rendered":"https:\/\/blog.ultrahuman.com\/blog\/?p=50469"},"modified":"2026-06-03T18:26:10","modified_gmt":"2026-06-03T12:56:10","slug":"do-nad-supplements-actually-work-nmn-vs-nr-vs-niagen-compared","status":"publish","type":"post","link":"https:\/\/blog.ultrahuman.com\/blog\/do-nad-supplements-actually-work-nmn-vs-nr-vs-niagen-compared\/","title":{"rendered":"Do NAD+ Supplements Actually Work? NMN vs NR vs Niagen Compared"},"content":{"rendered":"\n

NAD+ (nicotinamide adenine dinucleotide) supplements \u2014 NMN, NR, and Niagen \u2014 reliably raise blood NAD+ levels in human trials, but evidence for downstream clinical benefits beyond that biochemical change is still early.<\/strong> All three are precursor compounds your body converts into NAD+, a molecule your cells use to make energy and repair themselves that declines as you age. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two best-studied forms; Niagen is a brand-name patented form of NR chloride.<\/p>\n\n\n\n

The research has moved fast in the past five years but is still catching up to the marketing claims. Trials reliably show that these supplements raise blood NAD+ levels \u2014 the Conze trial of Niagen, for example, showed dose-dependent increases of 22%, 51%, and 142% across three doses. The harder question \u2014 whether higher NAD+ actually makes you live longer, feel more energetic, or perform better in daily life \u2014 is still being studied.<\/p>\n\n\n\n

This guide walks through what NAD+ does, how NMN, NR, and Niagen differ, what the human trials actually show, side effects and safety, a head-to-head comparison, and how to think about supplementation if you’re considering it.<\/p>\n\n\n\n

What NAD+ is and why people supplement it<\/h3>\n\n\n\n

NAD+ is a molecule your cells use to make energy, repair DNA, and keep mitochondria (the cellular structures that produce energy) working well. It’s involved in hundreds of processes across every tissue.<\/p>\n\n\n\n

NAD+ levels appear to decline as you age, with measurements suggesting meaningful drops by middle age, though the precise drop varies by tissue, person, and measurement method. The idea behind NAD+ supplementation \u2014 popularized by researchers like David Sinclair and clinicians like Peter Attia \u2014 is that restoring those levels could push back against age-related decline in cellular energy and repair.<\/p>\n\n\n\n

Your body makes NAD+ from a small set of precursor molecules. The two that have been studied most as supplements in humans are NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide). Niagen is a brand-name patented form of NR sold as a branded ingredient in many over-the-counter supplements (Tru Niagen, Basis, and others).<\/p>\n\n\n\n

NMN, NR, and Niagen \u2014 what’s the difference<\/h3>\n\n\n\n

NMN and NR are both raw materials your body converts into NAD+. They’re closely related \u2014 NMN is one step closer to NAD+, and ongoing research is sorting out whether oral NMN reaches your cells intact or is broken down to NR first in the gut. Whether the route taken affects how well NMN works versus NR is still debated; what’s clear is that both raise blood NAD+ levels when you take them.<\/p>\n\n\n\n

NMN (nicotinamide mononucleotide)<\/strong> has been studied for muscle insulin sensitivity, aerobic capacity, and sleep quality, with mostly positive findings on the biochemistry side and mixed-to-promising findings on the clinical side.<\/p>\n\n\n\n

NR (nicotinamide riboside)<\/strong> has been studied longer and in more trials than NMN, with the largest body of safety and dosing data in humans.<\/p>\n\n\n\n

Niagen<\/strong> is a brand-name patented form of NR \u2014 the same molecule as generic NR but with specific manufacturing and quality testing behind it. Products like Tru Niagen and Basis use Niagen as their active ingredient. When you pay extra for a “Niagen” supplement, you’re paying for the brand and the quality control, not a different molecule.<\/p>\n\n\n\n

The simple way to think about it: NMN and NR both end up at the same place \u2014 NAD+ in your cells. The differences are in how they get there, how much evidence each has behind it, and what they cost.<\/p>\n\n\n\n

What the human trials actually show<\/h3>\n\n\n\n

Three human randomized controlled trials (RCTs) anchor the strongest evidence base for NAD+ precursor supplementation:<\/p>\n\n\n\n

Yoshino et al. 2021 (Science<\/em>)<\/strong> \u2014 a randomized, placebo-controlled trial of 250 mg\/day NMN for 10 weeks in 25 prediabetic, overweight or obese postmenopausal women<\/a> found a significant increase in muscle insulin sensitivity (~25%) in the NMN group versus placebo (Yoshino et al., Science<\/em> 2021, PMID 33888596<\/a>). This was a small but well-conducted trial in a specific population; it doesn’t directly generalize to healthy adults.<\/p>\n\n\n\n

Yi et al. 2023 (Geroscience<\/em>)<\/strong> \u2014 a multicenter, double-blind, placebo-controlled, dose-dependent NMN trial in 80 healthy middle-aged adults<\/a> tested 300, 600, and 900 mg\/day for 60 days. The NMN groups had dose-dependent increases in blood NAD+ levels and improved performance on the 6-minute walk test, an exploratory functional endpoint; no significant safety concerns were reported (Yi et al., Geroscience<\/em> 2023, PMID 36482258<\/a>).<\/p>\n\n\n\n

Conze et al. 2019 (Scientific Reports<\/em>)<\/strong> \u2014 an 8-week randomized, double-blind, placebo-controlled trial of Niagen (NR chloride) at 100, 300, and 1000 mg\/day in 140 healthy overweight adults<\/a> showed dose-dependent increases in whole blood NAD+ of 22%, 51%, and 142%, with no clinically significant safety findings (Conze et al., Sci Rep<\/em> 2019, PMID 31278280<\/a>). The trial was sponsored by ChromaDex, the maker of Niagen, with this conflict disclosed in the published paper.<\/p>\n\n\n\n

The consistent finding: NAD+ precursor supplementation reliably increases blood NAD+ levels at standard doses. The harder question \u2014 whether these biochemical changes translate to longevity, healthspan, energy, or disease-prevention benefits at population scale \u2014 has weaker, more heterogeneous evidence. Most longer-duration trials are still in progress, and results so far have been mixed across endpoints (cognition, cardiovascular markers, muscle function, sleep quality).<\/p>\n\n\n\n

Side effects and safety<\/h3>\n\n\n\n

Across the published RCTs, NMN and NR (including Niagen) have been well tolerated at the doses studied (100-1,000+ mg\/day) over weeks to months. Common reported side effects when they occur are mild and dose-dependent:<\/p>\n\n\n\n